Response to Vyse et al., "A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK"

Expert Rev Vaccines. 2022 Jun;21(6):869-870. doi: 10.1080/14760584.2022.2047023. Epub 2022 Mar 22.
No abstract available

Keywords: immunity; immunocompetent; immunogenicity; pneumococcal; vaccine.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Decision Making
  • Humans
  • Pneumococcal Infections* / epidemiology
  • Pneumococcal Infections* / prevention & control
  • Streptococcus pneumoniae
  • United Kingdom
  • Vaccination